The Ubiquitin Ligase UBE3B, Disrupted in Intellectual Disability and Absent Speech, Regulates Metabolic Pathways by Targeting BCKDK

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1818751116
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Metabolic Syndrome and Intellectual Disability

British Journal of Psychiatry
MedicinePsychiatryMental Health
2007English

Erratum To: Haploinsufficiency of the E3 Ubiquitin-Protein Ligase Gene TRIP12 Causes Intellectual Disability With or Without Autism Spectrum Disorders, Speech Delay, and Dysmorphic Features

Human Genetics
Genetics
2017English

Genetic Regulation of Metabolic Pathways in Β-Cells Disrupted by Hyperglycemia

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

The Ubiquitin Ligase Synoviolin Up-Regulates Amyloid Β Production by Targeting a Negative Regulator of Γ-Secretase, Rer1, for Degradation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Fbxo45, a Novel Ubiquitin Ligase, Regulates Synaptic Activity

Neuroscience Research
MedicineNeuroscience
2010English

Ubiquitin Ligase Siah2 Regulates RevErbα Degradation and the Mammalian Circadian Clock

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2015English

Major Synaptic Signaling Pathways Involved in Intellectual Disability

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2012English

The Deubiquitylase USP2 Regulates the LDLR Pathway by Counteracting the E3-Ubiquitin Ligase IDOLNovelty and Significance

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2016English

E3 Ubiquitin Ligase RNF126 Promotes Cancer Cell Proliferation by Targeting the Tumor Suppressor P21 for Ubiquitin-Mediated Degradation

Cancer Research
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy